CLINICAL TRIALS PROFILE FOR ONEXTON
✉ Email this page to a colleague
All Clinical Trials for ONEXTON
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT02578043 ↗ | A Study Comparing Clindamycin and Benzoyl Peroxide Gel 1.2%/3.75% to Onexton™ Gel in the Treatment of Acne Vulgaris | Completed | Taro Pharmaceuticals USA | Phase 1 | 2015-04-01 | The objectives of this study are to evaluate the therapeutic equivalence and safety. |
| NCT02616614 ↗ | Double-blind Placebo-controlled Trial of Generic Clindamycin/Benzoyl Peroxide Gel Versus Onexton Gel in Acne Vulgaris | Completed | Actavis Inc. | Phase 3 | 2015-05-01 | Actavis has developed a generic formulation of clindamycin 1.2% and benzoyl peroxide 3.75% gel. This study is designed to evaluate the safety and efficacy of this formulation in subjects with Acne Vulgaris |
| NCT03402893 ↗ | The Use of Onexton in Moderate Acne Vulgaris for Patients With Skin of Color | Completed | Derm Research, PLLC | Phase 4 | 2017-07-28 | This is a single-center, open label pilot study. The study is comprised of 5 study visits; Screening, Baseline, and Weeks 4, 8, and 16. All subjects will receive Onexton at Baseline and be instructed to apply the gel once daily to the face. The investigators will evaluate Investigator Global Assessment of acne (IGA), total lesion count, inflammatory lesion count, non-inflammatory lesion count, Investigator Global Assessment of Post-Inflammatory Hyperpigmentation and distribution of Post-Inflammatory Hyperpigmentation, adverse events and concomitant medications. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for ONEXTON
Condition Name
Clinical Trial Locations for ONEXTON
Trials by Country
Clinical Trial Progress for ONEXTON
Clinical Trial Phase
Clinical Trial Sponsors for ONEXTON
Sponsor Name
